Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer with a combination of an anti-VEGF antibody and an anti-tissue factor antibody-drug conjugate

Methods of treating cancer with a combination of an anti-VEGF antibody and an anti-tissue factor antibody-drug conjugate

US Patent 12453781 · Granted Oct 28, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use t2025
Methods of treating cancer with a combination of a platinum-based agent and an a2025
Methods of treating cancer with a combination of a platinum-based agent and an a2025
Methods of treating cancer with a combination of a platinum-based agent and an a2025
Methods of treating cancer with a combination of a platinum-based agent and an a2025
Anti-DR5 antibodies and methods of use thereof2025